- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01656954
Predicting Volume Response Study (PVRS)
August 15, 2016 updated by: University of Pennsylvania
Change in Stroke Volume During Passive Leg Raise Predicts Volume Challenge Response as Measured by Arterial Pressure Cardiac Output Monitor.
The purpose of this study is to understand and document measurements in heart stroke volume (the volume or amount of blood pumped per heart beat) and cardiac output (the volume or amount of blood pumped by your heart per minute) during a passive leg raise maneuver (elevation of the legs), and to determine if these measurements can predict changes in the same as a result of fluid or blood product administration.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The administration of intravenous fluid and blood products for treatment of hypovolemia is common in the ICU setting.
Static resuscitation endpoints such as heart rate, blood pressure, and CVP are frequently used to guide this therapy, despite compelling evidence they are unreliable in predicting patient response to therapeutic volume administration or as an endpoint for ongoing therapy.
Dynamic parameters such as continuous stroke volume and cardiac output (index) monitoring, along with pulse pressure and stroke volume variance measures are more reliable in predicting and measuring response to fluid challenge and therapeutic volume administration.
The purpose of this study is to observe changes in stroke volume (SV) and cardiac output (CO) during a passive leg raise maneuver (PLR) as a surrogate to volume challenge, and to determine if these changes can predict changes in the same parameters with fluid or blood product administration in surgical patients.
The PLR maneuver involves positioning the patient to the supine position and elevating the legs to 45 degrees.
The PLR moves blood from the capacitance vessels of the legs to the heart, potentially improving stroke volume (SV) and cardiac output (CO), without the administration of intravenous fluids.
PLR may predict whether SV or CO would improve with administration of fluids, and guide decisions on whether fluid administration would be beneficial.
Stroke volume and cardiac output (index) will be calculated by a commercial pulse power arterial pressure cardiac output system (LIDCORapid), using the patients' measured heart rate and blood pressure imported from the bedside monitor.
By using the combination of a reversible volume challenge (PLR) and a minimally invasive monitoring system, it is hoped that a more reliable method will emerge to both predict a response and guide therapeutic volume administration, while reducing the risk associated with fluid volume overload.
Study Type
Observational
Enrollment (Actual)
7
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adult patients admitted to the Rhoads 5 SICU on the Trauma/Surgical Critical Service who would be anticipated to receive IV fluids or blood as part of their treatment.
Description
Inclusion Criteria:
- Patients 18 years or older admitted to the Surgical Intensive Care Unit, anticipated to receive IV fluid boluses or blood products, with the presence of an arterial pressure line.
Exclusion Criteria:
- patients under 18 years of age,
- pregnancy,
- prisoners,
- inability to lay in the supine position,
- conditions of the lower extremities,
- pelvis or spine that preclude elevation of the legs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Anticipated volume/blood administration
Patients who may receive IV fluid boluses or blood products for restoration of vascular volume.
Prior to receiving IV fluid boluses or blood products, the patient will undergo a passive leg raise.
(PLR)
|
From the supine position, the legs are elevated to 45 degrees above the resting surface for a period of 3 minutes.
At completion,the legs are lowered to the resting surface.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in baseline cardiac stroke volume
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Stroke volume is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Stroke volume is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in baseline stroke volume variance (SVV)
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Stroke volume variance is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Stroke volume variance is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
|
Change in baseline pulse pressure variance (PPV)
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Pulse pressure variance is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Pulse pressure variance is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
|
Change in baseline cardiac output
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Cardiac output is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Cardiac output is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
|
Change from baseline heart rate.
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Heart rate is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Heart rate is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
|
Change in baseline blood pressure (BP)
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Blood pressure is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Blood pressure is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
|
Change in baseline central venous pressure (CVP).
Time Frame: Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Central venous pressure is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR.
Central venous pressure is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
|
Passive Leg Raise: Baseline and at 3 minutes. Fluid/blood administration: Baseline to completion of administration.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: John J Gallagher, MSN, RN, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
July 17, 2012
First Submitted That Met QC Criteria
August 2, 2012
First Posted (Estimate)
August 3, 2012
Study Record Updates
Last Update Posted (Estimate)
August 17, 2016
Last Update Submitted That Met QC Criteria
August 15, 2016
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 813558
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsCompletedWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedSepsis | Toxic-Shock Syndrome
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
King's College Hospital NHS TrustUniversity Hospital BirminghamCompletedTraumatic Haemorrhagic ShockUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
Assiut UniversityUnknown
-
University of ManitobaCanadian Institutes of Health Research (CIHR); CancerCare ManitobaTerminatedSeptic Shock | Vasodilatory ShockCanada, United States, Brazil, Greece, India, Pakistan, Philippines
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
Clinical Trials on Passive Leg Raise (PLR)
-
University Rovira i VirgiliHospital Universitari Joan XXIII de Tarragona.; Public Health Service of CataluñaUnknown
-
Medical Centre LeeuwardenCompleted
-
Beth Israel Deaconess Medical CenterBaxter Healthcare CorporationTerminatedSeptic Shock | Infection | Congestive Heart Failure | Hypovolemia | Acute Heart Failure | HypervolemiaUnited States
-
Tri-Service General HospitalCompletedTachycardia | HypotensionTaiwan
-
Southeast University, ChinaZhongda HospitalCompleted
-
University of SaskatchewanCompleted
-
Karolinska InstitutetCompletedFluid Therapy | Cardiovascular System | Stroke VolumeSweden
-
Amsterdam UMC, location VUmcCompletedHypovolemia | Perioperative/Postoperative ComplicationsNetherlands
-
Fortis Hospital, IndiaUnknown
-
University Hospital DubravaUnknownCritical Illness | Surgery | Cardiac Output, LowCroatia